A Feasibility Study of Image Guided Noninvasive Single Fraction Stereotactic Radiosurgery for the Treatment of Brain Metastases
| Status: | Completed |
|---|---|
| Conditions: | Brain Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | October 2005 |
| End Date: | July 2010 |
Stereotactic radiosurgery (SRS) is a way to accurately treat brain tumors. SRS involves the
use of a special head frame to keep the head from moving during treatment. The head frame
makes very accurate treatment possible. The frame must be attached to the skull with special
pins. It feels very tight and can hurt. A special immobilization device can be used to keep
the head from moving.
This device does not need any pins and does not hurt. We would like to see if the new way of
holding the head still can be used for SRS. This is the purpose of the study. New X-Ray
machines can be used to find if the head has moved in the mask. We hope that we can use
these new tools to treat brain tumors just as accurately without using a head frame. It will
make treatment more comfortable for the patient. This is why we are asking patients to join
the study.
use of a special head frame to keep the head from moving during treatment. The head frame
makes very accurate treatment possible. The frame must be attached to the skull with special
pins. It feels very tight and can hurt. A special immobilization device can be used to keep
the head from moving.
This device does not need any pins and does not hurt. We would like to see if the new way of
holding the head still can be used for SRS. This is the purpose of the study. New X-Ray
machines can be used to find if the head has moved in the mask. We hope that we can use
these new tools to treat brain tumors just as accurately without using a head frame. It will
make treatment more comfortable for the patient. This is why we are asking patients to join
the study.
Inclusion Criteria:
- Histologically confirmed malignancy with the presence of intraparenchymal brain
metastases.
- A diagnostic contrast enhanced MRI demonstrating the presence of brain metastases
performed within two weeks prior to registration.
- Age ≥ 18 years.
- Must be scheduled or planning to be scheduled for SRS treatment.
- Karnofsky performance status ≥60.
- Patient must sign a study-specific informed consent form. If the patient's mental
status precludes his/her giving informed consent, written informed consent may be
given by the patient's legal representative.
Exclusion Criteria:
- Unable to provide informed consent
- Major medical illness including poor cardiac or pulmonary status which would result
in inability of the patient to lie down for the procedure.
- Inability to obtain histologic proof of malignancy.
- Younger than 18 years of age.
- Serum creatinine > 1.3 mg/dl.
- Karnofsky performance status of ≤50.
- Allergy to either CT or MR contrast dyes.
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
